Guardant Health (GH) Gross Profit (2017 - 2026)

Guardant Health has disclosed Gross Profit across 10 years of filings, most recently posting $196.7 million for Q1 2026.

• Gross Profit for Q1 2026 came in at $196.7 million, up 52.81% year-over-year; the trailing twelve-month figure through Mar 2026 was $769.0 million (up 47.11% YoY), and the FY2025 annual result was $633.0 million, up 40.91% from the prior year.
• Gross Profit came in at $196.7 million for Q1 2026 at Guardant Health, down from $283.5 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $287.8 million in Q4 2023 to a low of $31.7 million in Q1 2022.
• The 5-year median for Gross Profit is $104.8 million (2024), against an average of $119.1 million.
• Across the five-year window, Gross Profit surged 532.87% in 2023 and plunged 40.16% in 2024, its largest moves.
• Guardant Health's Gross Profit stood at $45.5 million in 2022, then soared by 532.87% to $287.8 million in 2023, then sank by 40.16% to $172.2 million in 2024, then jumped by 64.67% to $283.5 million in 2025, then slumped by 30.61% to $196.7 million in 2026.
• The last three Gross Profit figures came in at $196.7 million (Q1 2026), $283.5 million (Q4 2025), and $137.8 million (Q3 2025), per Business Quant data.